Ohio | 001-11593 | 31-1414921 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation or organization) | File Number) | Identification No.) |
14111 Scottslawn Road, Marysville, Ohio | 43041 |
(Address of principal executive offices) | (Zip Code) |
Exhibit No. | Description |
99.1 | News release issued by The Scotts Miracle-Gro Company on August 9, 2012 |
THE SCOTTS MIRACLE-GRO COMPANY | |
Dated: August 9, 2012 | By: /s/ David C. Evans |
Printed Name: David C. Evans | |
Title: Chief Financial Officer and Executive Vice President, Strategy and Business Development |
Exhibit No. | Exhibit Description |
99.1 | News release issued by The Scotts Miracle-Gro Company on August 9, 2012 |
The Scotts Miracle-Gro Company | NEWS |
• | The ongoing governmental investigations regarding the Company’s compliance with the Federal Insecticide, Fungicide, and Rodenticide Act of 1947, as amended, could adversely affect the Company’s financial condition, results of operations or cash flows; |
• | Compliance with environmental and other public health regulations could increase the Company’s costs of doing business or limit the Company’s ability to market all of its products; |
• | Disruptions in availability or increases in the prices of raw materials could adversely affect the Company’s results of operations; |
• | The highly competitive nature of the Company’s markets could adversely affect its ability to maintain or grow revenue; |
• | Because of the concentration of the Company’s sales to a small number of retail customers, the loss of one or more of, or significant reduction in orders from, its top customers could adversely affect the Company’s financial results; |
• | Adverse weather conditions could adversely impact financial results; |
• | The Company’s international operations make the Company susceptible to the costs and risks associated with operating internationally; |
• | The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to the Company’s business; |
• | If Monsanto Company were to terminate the Marketing Agreement for consumer Roundup products, the Company would lose a substantial source of future earnings and overhead expense absorption; |
• | Hagedorn Partnership, L.P. beneficially owns approximately 31% of the Company’s common shares and can significantly influence decisions that require the approval of shareholders; |
• | The Company may pursue acquisitions, dispositions, investments, dividends, share repurchases and/or other corporate transactions that it believes will maximize equity returns of its shareholders but may involve risks. |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
Footnotes | June 30, 2012 | July 2, 2011 | % Change | June 30, 2012 | July 2, 2011 | % Change | |||||||||||||||||||
Net sales | $ | 1,062.2 | $ | 1,058.7 | — | % | $ | 2,446.9 | $ | 2,418.5 | 1% | ||||||||||||||
Cost of sales | 695.5 | 657.5 | 1,592.4 | 1,503.4 | |||||||||||||||||||||
Cost of sales - product registration and recall matters | 0.2 | 1.1 | 0.4 | 3.2 | |||||||||||||||||||||
Gross profit | 366.5 | 400.1 | (8 | )% | 854.1 | 911.9 | (6 | )% | |||||||||||||||||
% of sales | 34.5 | % | 37.8 | % | 34.9 | % | 37.7 | % | |||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||
Selling, general and administrative | 197.5 | 192.4 | 3 | % | 557.5 | 551.8 | 1 | % | |||||||||||||||||
Impairment, restructuring and other charges | (0.4) | 13.8 | 7.8 | 13.8 | |||||||||||||||||||||
Product registration and recall matters | 3.8 | 5.7 | 7.4 | 7.8 | |||||||||||||||||||||
Other income, net | (2.4 | ) | (4.2 | ) | (4.6 | ) | (5.0 | ) | |||||||||||||||||
Income from operations | 168.0 | 192.4 | (13 | )% | 286.0 | 343.5 | (17 | )% | |||||||||||||||||
% of sales | 15.8 | % | 18.2 | % | 11.7 | % | 14.2 | % | |||||||||||||||||
Costs related to refinancing | — | 1.2 | — | 1.2 | |||||||||||||||||||||
Interest expense | 16.6 | 14.0 | 49.8 | 37.3 | |||||||||||||||||||||
Income from continuing operations before income taxes | 151.4 | 177.2 | (15 | )% | 236.2 | 305.0 | (22.6 | )% | |||||||||||||||||
Income tax expense from continuing operations | 56.4 | 65.5 | 87.9 | 111.4 | |||||||||||||||||||||
Income from continuing operations | 95.0 | 111.7 | (15 | )% | 148.3 | 193.6 | (23 | )% | |||||||||||||||||
Income (loss) from discontinued operations, net of tax | (3 | ) | (1.7 | ) | (0.1 | ) | (1.7 | ) | 27.7 | ||||||||||||||||
Net income | $ | 93.3 | $ | 111.6 | $ | 146.6 | $ | 221.3 | |||||||||||||||||
Basic income per common share: | (1 | ) | |||||||||||||||||||||||
Income from continuing operations | $ | 1.55 | $ | 1.73 | (10 | )% | $ | 2.43 | $ | 2.95 | (18 | )% | |||||||||||||
Income (loss) from discontinued operations | (0.02 | ) | — | (0.03 | ) | 0.42 | |||||||||||||||||||
Net income | $ | 1.53 | $ | 1.73 | $ | 2.40 | $ | 3.37 | |||||||||||||||||
Diluted income per common share: | (2 | ) | |||||||||||||||||||||||
Income from continuing operations | $ | 1.53 | $ | 1.69 | (9 | )% | $ | 2.39 | $ | 2.89 | (17 | )% | |||||||||||||
Income (loss) from discontinued operations | (0.03 | ) | — | (0.03 | ) | 0.41 | |||||||||||||||||||
Net income | $ | 1.50 | $ | 1.69 | $ | 2.36 | $ | 3.30 | |||||||||||||||||
Common shares used in basic income per share calculation | 61.1 | 64.5 | (5 | )% | 61.0 | 65.6 | (7 | )% | |||||||||||||||||
Common shares and potential common shares used in diluted income per share calculation | 62.2 | 66.2 | (6 | )% | 62.0 | 67.1 | (8 | )% | |||||||||||||||||
Non-GAAP results from continuing operations: | |||||||||||||||||||||||||
Adjusted income from continuing operations | (4 | ) | $ | 99.4 | $ | 126.7 | (22 | )% | $ | 160.5 | $ | 211.4 | (24 | )% | |||||||||||
Adjusted diluted income per share from continuing operations | (2) (4) | $ | 1.60 | $ | 1.91 | (16 | )% | $ | 2.59 | $ | 3.15 | (18 | )% | ||||||||||||
Adjusted EBITDA | (3) (4) | $ | 185.0 | $ | 227.9 | (19 | )% | $ | 338.0 | $ | 420.2 | (20 | )% | ||||||||||||
Note: See accompanying footnotes on page 10. |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||
June 30, 2012 | July 2, 2011 | % Change | June 30, 2012 | July 2, 2011 | % Change | ||||||||||||||||
Net Sales: | |||||||||||||||||||||
Global Consumer | $ | 960.7 | $ | 951.6 | 1 | % | $ | 2,229.4 | $ | 2,225.2 | — | % | |||||||||
Scotts LawnService® | 87.8 | 82.4 | 7 | % | 161.3 | 152.2 | 6 | % | |||||||||||||
Segment total | 1,048.5 | 1,034.0 | 1 | % | 2,390.7 | 2,377.4 | 1 | % | |||||||||||||
Corporate & Other | 13.7 | 24.7 | 56.2 | 41.1 | |||||||||||||||||
Consolidated | $ | 1,062.2 | $ | 1,058.7 | — | % | $ | 2,446.9 | $ | 2,418.5 | 1 | % | |||||||||
Income from Continuing Operations before Income Taxes: | |||||||||||||||||||||
Global Consumer | $ | 171.7 | $ | 209.9 | (18 | )% | $ | 377.4 | $ | 453.8 | (17 | )% | |||||||||
Scotts LawnService® | 22.4 | 22.4 | — | % | 4.9 | 2.7 | 81 | % | |||||||||||||
Segment total | 194.1 | 232.3 | 382.3 | 456.5 | |||||||||||||||||
Corporate & Other | (20.3 | ) | (16.2 | ) | (74.0 | ) | (80.1 | ) | |||||||||||||
Intangible asset amortization | (2.2 | ) | (3.1 | ) | (6.7 | ) | (8.1 | ) | |||||||||||||
Product registration and recall matters | (4.0 | ) | (6.8 | ) | (7.8 | ) | (11.0 | ) | |||||||||||||
Impairment, restructuring and other charges | 0.4 | (13.8 | ) | (7.8 | ) | (13.8 | ) | ||||||||||||||
Costs related to refinancing | — | (1.2 | ) | — | (1.2 | ) | |||||||||||||||
Interest expense | (16.6 | ) | (14.0 | ) | (49.8 | ) | (37.3 | ) | |||||||||||||
Consolidated | $ | 151.4 | $ | 177.2 | (15 | )% | $ | 236.2 | $ | 305.0 | (23 | )% |
JUNE 30, 2012 | JULY 2, 2011 | SEPTEMBER 30, 2011 | |||||||||
(UNAUDITED) | (UNAUDITED) | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 132.3 | $ | 164.3 | $ | 130.9 | |||||
Accounts receivable, net | 613.9 | 693.9 | 323.5 | ||||||||
Inventories | 469.3 | 442.2 | 387.0 | ||||||||
Prepaids and other current assets | 130.6 | 137.3 | 151.1 | ||||||||
Total current assets | 1,346.1 | 1,437.7 | 992.5 | ||||||||
Property, plant and equipment, net | 387.7 | 394.3 | 394.7 | ||||||||
Goodwill | 309.1 | 306.5 | 309.1 | ||||||||
Intangible assets, net | 308.7 | 343.2 | 319.6 | ||||||||
Other assets | 32.5 | 45.5 | 36.3 | ||||||||
Total assets | $ | 2,384.1 | $ | 2,527.2 | $ | 2,052.2 | |||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Current portion of debt | $ | 90.8 | $ | 2.1 | $ | 3.2 | |||||
Accounts payable | 242.8 | 258.8 | 150.0 | ||||||||
Other current liabilities | 476.6 | 490.2 | 315.4 | ||||||||
Total current liabilities | 810.2 | 751.1 | 468.6 | ||||||||
Long-term debt | 680.4 | 782.1 | 791.8 | ||||||||
Other liabilities | 219.5 | 225.7 | 232.0 | ||||||||
Total liabilities | 1,710.1 | 1,758.9 | 1,492.4 | ||||||||
Shareholders' equity | 674.0 | 768.3 | 559.8 | ||||||||
Total liabilities and shareholders’ equity | $ | 2,384.1 | $ | 2,527.2 | $ | 2,052.2 |
Three months ended June 30, 2012 | Three months ended July 2, 2011 | ||||||||||||||||||||||||||||||
As Reported | Product Registration and Recall Matters | Impairment, Restructuring and Other Charges | Adjusted | As Reported | Product Registration and Recall Matters | Impairment, Restructuring and Other Charges | Adjusted | ||||||||||||||||||||||||
Net sales | $ | 1,062.2 | $ | — | $ | — | $ | 1,062.2 | $ | 1,058.7 | $ | — | $ | — | $ | 1,058.7 | |||||||||||||||
Cost of sales | 695.5 | — | — | 695.5 | 657.5 | — | — | 657.5 | |||||||||||||||||||||||
Cost of sales - product registration and recall matters | 0.2 | 0.2 | — | — | 1.1 | 1.1 | — | — | |||||||||||||||||||||||
Gross profit | 366.5 | (0.2 | ) | — | 366.7 | 400.1 | (1.1 | ) | — | 401.2 | |||||||||||||||||||||
% of sales | 34.5 | % | 34.5 | % | 37.8 | % | 37.9 | % | |||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||
Selling, general and administrative | 197.5 | — | — | 197.5 | 192.4 | — | — | 192.4 | |||||||||||||||||||||||
Impairment, restructuring and other charges | (0.4 | ) | — | (0.4 | ) | — | 13.8 | — | 13.8 | — | |||||||||||||||||||||
Product registration and recall matters | 3.8 | 3.8 | — | — | 5.7 | 5.7 | — | — | |||||||||||||||||||||||
Other income, net | (2.4 | ) | — | — | (2.4 | ) | (4.2 | ) | — | — | (4.2 | ) | |||||||||||||||||||
Income from operations | 168.0 | (4.0 | ) | 0.4 | 171.6 | 192.4 | (6.8 | ) | (13.8 | ) | 213.0 | ||||||||||||||||||||
% of sales | 15.8 | % | 16.2 | % | 18.2 | % | 20.1 | % | |||||||||||||||||||||||
Costs related to refinancing | — | — | — | — | 1.2 | — | — | 1.2 | |||||||||||||||||||||||
Interest expense | 16.6 | — | — | 16.6 | 14.0 | — | — | 14.0 | |||||||||||||||||||||||
Income from continuing operations before income taxes | 151.4 | (4.0 | ) | 0.4 | 155.0 | 177.2 | (6.8 | ) | (13.8 | ) | 197.8 | ||||||||||||||||||||
Income tax expense from continuing operations | 56.4 | 0.1 | 0.7 | 55.6 | 65.5 | (0.8 | ) | (4.8 | ) | 71.1 | |||||||||||||||||||||
Income from continuing operations | $ | 95.0 | $ | (4.1 | ) | $ | (0.3 | ) | $ | 99.4 | $ | 111.7 | $ | (6.0 | ) | $ | (9.0 | ) | $ | 126.7 | |||||||||||
Basic income per share from continuing operations | $ | 1.55 | $ | (0.07 | ) | $ | (0.01 | ) | $ | 1.63 | $ | 1.73 | $ | (0.09 | ) | $ | (0.14 | ) | $ | 1.96 | |||||||||||
Diluted income per share from continuing operations | $ | 1.53 | $ | (0.07 | ) | $ | — | $ | 1.60 | $ | 1.69 | $ | (0.09 | ) | $ | (0.13 | ) | $ | 1.91 | ||||||||||||
Common shares used in basic income per share calculation | 61.1 | 61.1 | 61.1 | 61.1 | 64.5 | 64.5 | 64.5 | 64.5 | |||||||||||||||||||||||
Common shares and potential common shares used in diluted income per share calculation | 62.2 | 62.2 | 62.2 | 62.2 | 66.2 | 66.2 | 66.2 | 66.2 | |||||||||||||||||||||||
Calculation of Adjusted EBITDA: | |||||||||||||||||||||||||||||||
Income from continuing operations | $ | 95.0 | $ | 111.7 | |||||||||||||||||||||||||||
Income tax expense from continuing operations | 56.4 | 65.5 | |||||||||||||||||||||||||||||
Income from discontinued operations, net of tax (excluding impact of Global Pro sale) | — | 0.2 | |||||||||||||||||||||||||||||
Income tax expense from discontinued operations (excluding impact of Global Pro sale) | — | 0.1 | |||||||||||||||||||||||||||||
Costs related to refinancing | — | 1.2 | |||||||||||||||||||||||||||||
Interest expense | 16.6 | 14.0 | |||||||||||||||||||||||||||||
Interest expense from discontinued operations | — | — | |||||||||||||||||||||||||||||
Depreciation | 14.2 | 12.7 | |||||||||||||||||||||||||||||
Amortization (including Roundup) | 2.4 | 3.3 | |||||||||||||||||||||||||||||
Impairment, restructuring and other charges | — | 13.8 | |||||||||||||||||||||||||||||
Product registration and recall matters | 0.2 | 5.4 | |||||||||||||||||||||||||||||
Mark-to-market adjustments on derivatives | 0.2 | — | |||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 185.0 | $ | 227.9 | |||||||||||||||||||||||||||
Note: See accompanying footnotes on page 10. |
Nine Months Ended June 30, 2012 | Nine Months Ended July 2, 2011 | ||||||||||||||||||||||||||||||
As Reported | Product Registration and Recall Matters | Impairment, Restructuring and Other Charges | Adjusted | As Reported | Product Registration and Recall Matters | Impairment, Restructuring and Other Charges | Adjusted | ||||||||||||||||||||||||
Net sales | $ | 2,446.9 | $ | — | $ | — | $ | 2,446.9 | $ | 2,418.5 | $ | — | $ | — | $ | 2,418.5 | |||||||||||||||
Cost of sales | 1,592.4 | — | — | 1,592.4 | 1,503.4 | — | — | 1,503.4 | |||||||||||||||||||||||
Cost of sales - product registration and recall matters | 0.4 | 0.4 | — | — | 3.2 | 3.2 | — | — | |||||||||||||||||||||||
Gross profit | 854.1 | (0.4 | ) | — | 854.5 | 911.9 | (3.2 | ) | — | 915.1 | |||||||||||||||||||||
% of sales | 34.9 | % | 34.9 | % | 37.7 | % | 37.8 | % | |||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||
Selling, general and administrative | 557.5 | — | — | 557.5 | 551.8 | — | — | 551.8 | |||||||||||||||||||||||
Impairment, restructuring and other charges | 7.8 | — | 7.8 | — | 13.8 | — | 13.8 | — | |||||||||||||||||||||||
Product registration and recall matters | 7.4 | 7.4 | — | — | 7.8 | 7.8 | — | — | |||||||||||||||||||||||
Other income, net | (4.6 | ) | — | — | (4.6 | ) | (5.0 | ) | — | — | (5.0 | ) | |||||||||||||||||||
Income from operations | 286.0 | (7.8 | ) | (7.8 | ) | 301.6 | 343.5 | (11.0 | ) | (13.8 | ) | 368.3 | |||||||||||||||||||
% of sales | 11.7 | % | 12.3 | % | 14.2 | % | 15.2 | % | |||||||||||||||||||||||
Costs related to refinancing | — | — | — | — | 1.2 | — | — | 1.2 | |||||||||||||||||||||||
Interest expense | 49.8 | — | — | 49.8 | 37.3 | — | — | 37.3 | |||||||||||||||||||||||
Income from continuing operations before income taxes | 236.2 | (7.8 | ) | (7.8 | ) | 251.8 | 305.0 | (11.0 | ) | (13.8 | ) | 329.8 | |||||||||||||||||||
Income tax expense from continuing operations | 87.9 | (0.6 | ) | (2.8 | ) | 91.3 | 111.4 | (2.2 | ) | (4.8 | ) | 118.4 | |||||||||||||||||||
Income from continuing operations | $ | 148.3 | $ | (7.2 | ) | $ | (5.0 | ) | $ | 160.5 | $ | 193.6 | $ | (8.8 | ) | $ | (9.0 | ) | $ | 211.4 | |||||||||||
Basic income per share from continuing operations | $ | 2.43 | $ | (0.12 | ) | $ | (0.08 | ) | $ | 2.63 | $ | 2.95 | $ | (0.13 | ) | $ | (0.14 | ) | $ | 3.22 | |||||||||||
Diluted income per share from continuing operations | $ | 2.39 | $ | (0.12 | ) | $ | (0.08 | ) | $ | 2.59 | $ | 2.89 | $ | (0.13 | ) | $ | (0.13 | ) | $ | 3.15 | |||||||||||
Common shares used in basic income per share calculation | 61.0 | 61.0 | 61.0 | 61.0 | 65.6 | 65.6 | 65.6 | 65.6 | |||||||||||||||||||||||
Common shares and potential common shares used in diluted income per share calculation | 62.0 | 62.0 | 62.0 | 62.0 | 67.1 | 67.1 | 67.1 | 67.1 | |||||||||||||||||||||||
Calculation of Adjusted EBITDA: | |||||||||||||||||||||||||||||||
Income from continuing operations | $ | 148.3 | $ | 193.6 | |||||||||||||||||||||||||||
Income tax expense from continuing operations | 87.9 | 111.4 | |||||||||||||||||||||||||||||
Income from discontinued operations, net of tax (excluding impact of Global Pro sale) | — | 6.5 | |||||||||||||||||||||||||||||
Income tax expense from discontinued operations (excluding tax impact of Global Pro sale) | — | 2.6 | |||||||||||||||||||||||||||||
Costs related to refinancing | — | 1.2 | |||||||||||||||||||||||||||||
Interest expense | 49.8 | 37.3 | |||||||||||||||||||||||||||||
Interest expense from discontinued operations | — | 1.7 | |||||||||||||||||||||||||||||
Depreciation | 39.6 | 37.3 | |||||||||||||||||||||||||||||
Amortization (including Roundup) | 7.3 | 8.7 | |||||||||||||||||||||||||||||
Impairment, restructuring and other charges | 4.7 | 13.8 | |||||||||||||||||||||||||||||
Product registration and recall matters | 0.2 | 6.1 | |||||||||||||||||||||||||||||
Mark-to-market adjustments on derivatives | 0.2 | — | |||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 338.0 | $ | 420.2 | |||||||||||||||||||||||||||
Note: See accompanying footnotes on page 10. |
(1) | Basic income per common share amounts are calculated by dividing income from continuing operations, income (loss) from discontinued operations and net income by the weighted average number of common shares outstanding during the period. | |||||
(2) | Diluted income per common share amounts are calculated by dividing income from continuing operations, income (loss) from discontinued operations and net income by the weighted average number of common shares, plus all potential dilutive securities (common stock options, stock appreciation rights, performance shares, performance units, restricted stock and restricted stock units) outstanding during the period. | |||||
(3) | On February 28, 2011, the Company completed the sale of a significant majority of the assets of its global professional business (excluding the non-European professional seed business, “Global Pro”). As a result of the then-pending sale, effective in the Company's first quarter of fiscal 2011, the Company reclassified the assets and liabilities of Global Pro to assets and liabilities held for sale and included the results of operations of Global Pro in discontinued operations for all periods presented. | |||||
(4) | The Reconciliation of Non-GAAP Disclosure Items includes the following non-GAAP financial measures: Adjusted income from continuing operations and adjusted diluted income per common share from continuing operations - These measures exclude charges or credits relating to refinancings, impairments, restructurings, product registration and recall matters, discontinued operations and other unusual items such as costs or gains related to discrete projects or transactions that are apart from, and not indicative of, the results of the operations of the business. | |||||
Adjusted EBITDA - This measure is calculated as net income before interest, taxes, depreciation and amortization as well as certain other items such as the impact of the cumulative effect of changes in accounting, costs associated with debt refinancing and other non-recurring, non-cash items affecting net income. In addition, non-recurring cash items affecting net income or loss that are incurred between April 3, 2011 and June 30, 2012 in an aggregate amount not to exceed $40 million are also excluded from the determination of adjusted EBITDA. We believe this measure provides additional information for determining our ability to meet debt service requirements. The presentation of adjusted EBITDA herein is intended to be consistent with the calculation of that measure as required by our borrowing arrangements, and used to calculate a leverage ratio (maximum of 3.50 at June 30, 2012) and an interest coverage ratio (minimum of 3.50 for the twelve months ended June 30, 2012). The Company was in compliance with the terms of all debt covenants at June 30, 2012. | ||||||
The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that certain non-GAAP financial measures used in managing the business may provide users of this financial information additional meaningful comparison between current results and results in prior operating periods. The Company believes that these non-GAAP financial measures are the most indicative of the Company's ongoing earnings capabilities and that disclosure of these non-GAAP financial measures therefore provides useful information to investors and other users of its financial statements, such as lenders. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the Company's reported results prepared in accordance with GAAP. |